| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 152.46K | — |
| Operating expense | — | — |
| Net income | -3.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, DARE returned -61.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -57.5% |
| 1 year | -61.3% |
| 5 years | -96.1% |
| 10 years | -99.3% |
| All-time high | $1,081.20 (Mar 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in DARE would be worth today ›No. Daré Bioscience, Inc. has not paid a dividend in the past 12 months.
Daré Bioscience, Inc. stock trades on NASDAQ under the ticker symbol DARE.
Daré Bioscience, Inc. is part of the Healthcare sector.
Daré Bioscience, Inc. has a market cap of 15.89M USD, based on the latest quote.
Daré Bioscience, Inc. is scheduled to report earnings on Nov 12, 2026.
